Home
Companies
Catalysts
Deep Dives
IgG4-related disease
IgG4-RD · Immunology · 2 drugs · 1 indications
Competitive Landscape (2 drugs)
Drug
Company
Mechanism
Modality
Route
Stage
Zilbrysq
UCB
C5 inhibitor
Peptide
SC
APPROVED
UPLIZNA
AMGN
Anti-CD19 monoclonal antibody
Monoclonal antibody
IV
APPROVED
Indications (1)
IgG4-related disease
Zilbrysq
PHASE2
UPLIZNA
APPROVED
Data from Supabase · Updated 2026-03-24